Investors Urged to Take Action in PepGen Securities Case

Author: Logan Wright Updated: 07-03-2025 07:40 AM

Investigation into PepGen Inc. Securities Claims

Faruqi & Faruqi, LLP, recognized as a national securities law firm, has launched an investigation concerning potential claims on behalf of investors in PepGen Inc. (NASDAQ: PEPG). If you experienced losses while investing in PepGen, it’s crucial to understand your legal rights and options available to you.

Reach Out for Legal Support

Faruqi & Faruqi’s Securities Litigation Partner, Josh Wilson, is actively encouraging investors to contact him directly. If you have purchased or acquired securities in PepGen during a recent period and need legal advice, feel free to reach out at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss how to proceed.

Understanding the Allegations Against PepGen

The investigation revolves around allegations that the company and its executives may have violated federal securities laws. Specific claims suggest that PepGen made misleading statements regarding the effectiveness of its product PGN-EDO51. Concerns have been raised about the conduct of the CONNECT2 study, compounding worries about the product's safety and efficacy.

Latest Developments

In recent announcements, PepGen has reported that the results from its studies have not met investor expectations. For instance, on a specific date, the firm stated they achieved a mean absolute dystrophin level of only 0.61% of normal during its clinical study. Analysts noted this was below PepGen’s anticipated levels, leading to investor disappointment.

Impact on Stock Prices

Following these revelations, PepGen's stock saw significant declines. Reports indicate substantial drops following company announcements. For instance, after an unfavorable report, the stock fell by over 32% in a single day, reflecting investor concern over the management of the company’s trials.

Your Role as an Investor

As an investor, you have options regarding how to address your concerns about the company. You may choose to be involved as a lead plaintiff in any ongoing class action lawsuits related to PepGen's alleged misconduct. The lead plaintiff represents the interests of the wider group of affected shareholders.

Next Steps and Legal Options

Faruqi & Faruqi encourages any shareholders or employees who have information regarding PepGen's activities to come forward. Whistleblowers and previous employees might have insights relevant to the ongoing investigation.

Additional Information

If you wish to learn more about the potential class action concerning PepGen or to receive updates on next legal moves, please contact Faruqi & Faruqi directly. They are committed to supporting affected investors and addressing the issue comprehensively.

Frequently Asked Questions

What should I do if I invested in PepGen?

If you suffered losses in PepGen, consider reaching out to a securities attorney for personalized advice regarding your case.

What is the role of a lead plaintiff?

The lead plaintiff represents the class in lawsuit proceedings and oversees the litigation process to advocate for the interests of all plaintiffs.

How can I get updates on the investigation?

You can stay informed by contacting the law firm or checking their website for the latest news regarding the case.

Who can join the class action lawsuit?

Anyone who purchased shares of PepGen and experienced financial losses related to the company’s disclosures may be eligible to participate in the class action.

Can I still join the lawsuit if I've missed deadlines?

It’s essential to act quickly, but contacting a legal professional can help clarify options even if you believe you've missed deadlines.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.